Conlan Lindus A, McNees Carolyn J, Heierhorst Jörg
St Vincent's Institute of Medical Research, 9 Princes Street, Fitzroy, Victoria 3065, Australia.
Oncogene. 2004 Jan 8;23(1):307-10. doi: 10.1038/sj.onc.1207119.
Promyelocytic leukemia protein (PML) nuclear bodies (NBs) are present in variable number in most human cell types and have been linked to various cellular functions, including roles as depots for DNA repair proteins. Here, we show that treatment of human cells with DNA methylating agents leads to redistribution of PML from NBs to a diffuse nuclear localization. Biochemically, this correlates with a specific reduction of PML levels in the nuclear matrix fraction without affecting total PML levels. Similar results were obtained for the other major PML NB component, the Sp100 protein, indicating that DNA methylating agents lead to a general disassembly of PML NBs. Similar to the dispersal of PML NBs in response to some viral infections, PML redistribution after DNA damage was inhibited by the proteasome inhibitor MG132. We propose that the regulated dispersal of PML NBs may facilitate the enhanced release of DNA repair proteins from NB depots in order to respond adequately to extensive DNA damage.
早幼粒细胞白血病蛋白(PML)核体(NBs)在大多数人类细胞类型中的数量各不相同,并与多种细胞功能相关,包括作为DNA修复蛋白的储存库。在此,我们表明用DNA甲基化剂处理人类细胞会导致PML从核体重新分布到弥散的核定位。从生化角度来看,这与核基质部分中PML水平的特异性降低相关,而不影响总PML水平。对于另一种主要的PML核体成分Sp100蛋白,也获得了类似的结果,表明DNA甲基化剂会导致PML核体的普遍解体。与PML核体在某些病毒感染后发生的分散情况类似,蛋白酶体抑制剂MG132可抑制DNA损伤后PML的重新分布。我们提出,PML核体的调控性分散可能有助于从核体储存库中增强释放DNA修复蛋白,以便对广泛的DNA损伤做出充分反应。